SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

GLENMARK PHARMACEUTICALS

BSE: 532296 29 Jul 2025
Healthcare
₹ 2230.5
Glenmark Pharmaceuticals ltd specializes in Pharmaceuticals within the Healthcare sector.

GLENMARK PHARMACEUTICALS - Share Price & Details

Market Cap
₹60,899
High /Low
2,286 / 1,275
Stock P/E
46.2
Book Value
₹314.0
Dividend Yield
0.12
ROCE
19.4
ROE
₹15.8
Face Value
1.0
PEG Ratio
7.39
EVEBITDA
₹25.0
Debt
2,473
CMP / FCF
-68.6
Debt to equity
₹0.28
NP Ann
1,047
High price all time
2,286
Piotroski score
₹5.0
Graham Number
512.0
No. Eq. Shares
28.2
Net CF
₹-38.5
Net profit
1,047
Price to book value
6.88
Interest Coverage
₹9.56
Low price all time
109.0
Industry PE
34.0
Reserves
₹8,821
Free Cash Flow
₹-1,575

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,3.25-4.52NA-18.440
GLENMARK PHARMACEUTICALS LTD.20,979.451,477.6020,094.935.2460,89946.2
Alkem Laboratories Limited21,565.302,769.4020,449.4018.896061228.0
GLAXOSMITHKLINE PHARMACEUTICAL10,055.402,601.409,660.8015.355327561.0

Peer Comparison Chart


About GLENMARK PHARMACEUTICALS

Glenmark Pharmaceuticals ltd, with Security Code 532296, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Glenmark Pharmaceuticals Limited (532296) Stock Experiences Sudden Dip - Remarkable growth

(23 Jul 2025)
Glenmark Pharmaceuticals Limited (532296) Stock Experiences Sudden Dip ✌️【Market Discussions】✌️ Experience smarter investing with...
Read more →

Glenmark, Laurus: 4 pharma stocks gain up to 79% in 5 months; time to exit?

(23 Jul 2025)
The daily RSI, a key momentum indicator, shows that these 4 pharma stocks namely - Gland Pharma, Glenmark, Biocon and Laurus Labs are...
Read more →

Glenmark Pharmaceuticals Limited (GLENMARK) to Launch New Product Line - Tremendous growth potential

(23 Jul 2025)
Glenmark Pharmaceuticals Limited (GLENMARK) to Launch New Product Line ✌️【Stock Analysis】✌️ Our in-depth financial models assess earnings...
Read more →

Technical Analysis: Glenmark Pharmaceuticals Limited (532296) - Market-beating returns

(23 Jul 2025)
Technical Analysis: Glenmark Pharmaceuticals Limited (532296) ✌️【Growth Stocks】✌️ Stock group predictions and real-time quotes for global...
Read more →

Glenmark Pharma's North Carolina facility gets 5 USFDA observations; no data integrity issues

(23 Jul 2025)
Glenmark Pharmaceuticals Ltd on Wednesday informed bourses that the United States Food and Drug Administration (USFDA) conducted a Good Manufacturing...
Read more →

Glenmark Pharma will turn cash positive with AbbVie's licensing deal: S&P

(19 Jul 2025)
S&P Global Ratings projects Glenmark Pharmaceuticals will achieve a net cash positive position following its licensing agreement with AbbVie...
Read more →

Company Updates